Skip to main content

Table 1 Patient demographics and comparisons

From: The use of dielectric blood coagulometry in the evaluation of coagulability in patients with peripheral arterial disease

  

1 MHz, Tmax

10 MHz, Tmax

Variables

Number

Median

P-value

Median

P-value

Gender (Male: Female)

41: 8

1320: 1260

0.569

1620: 1500

0.705

Smoking history (+: -)

42: 7

1320: 1320

0.841

1560: 1800

0.852

Hypertension (+: -)

32: 17

1290: 1440

0.338

1500: 1740

0.152

Dyslipidemia (+: -)

25: 24

1260: 1440

0.173

1500: 1650

0.652

Coronary artery disease (+: -)

5: 44

1320: 1320

0.987

1740: 1560

0.741

Cerebrovascular disease (+: -)

9: 40

1200: 1410

0.1473

1500: 1650

0.224

Chronic kidney disease (+: -)

11: 38

1080: 1380

0.167

1260: 1710

0.052

Diabetes mellitus (+: -)

22: 27

1170: 1500

0.010

1470: 1800

0.011

Ca-blocker (+: -)

24: 25

1320: 1320

0.711

1500: 1680

0.331

β-blocker (+: -)

6: 43

1500: 1320

0.492

1680: 1560

0.783

ACE-I (+: -)

2: 47

1440: 1320

0.667

1620: 1560

0.859

ARB (+: -)

20: 29

1290: 1320

0.714

1500: 1680

0.154

Statin (+: -)

22: 27

1260: 1440

0.487

1620: 1560

0.840

Antiplatelet (+: -)

44: 5

1350: 1320

0.620

1560: 1620

0.408

  1. IQR interquartile range; ACE-I angiotensin converting enzyme – inhibitor; ARB angiotensin II receptor blocker
Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us